Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News ProNAi Therapeutics DNAI

"ProNAi Therapeutics Inc is a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi technology platform."
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:DNAI)

ProNAi Relaunched as Sierra Oncology to Advance DDR-Based Cancer Drugs

Canada NewsWire January 9, 2017

DNAI DEADLINE ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving ProNAi Therapeutics, Inc. and a Lead Plaintiff Deadline of January 9, 2017

GlobeNewswire January 6, 2017

Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming Deadline to File Lead Plaintiff Papers in ProNAi Therapeutics, Inc. (NASDAQ: DNAI) Securities Case

GlobeNewswire January 4, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of a Class Action Lawsuit Against ProNAi Therapeutics, Inc. and a Lead Plaintiff Deadline of January 9, 2017 – DNAI

GlobeNewswire January 4, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Commencement of a Class Action Lawsuit Against ProNAi Therapeutics, Inc. and a Lead Plaintiff Deadline of January 9, 2017

Business Wire December 29, 2016

DNAI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving ProNAi Therapeutics, Inc. and a Lead Plaintiff Deadline of January 9, 2017

Business Wire December 21, 2016

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of ProNAi Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire December 17, 2016

DNAI INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving ProNAi Therapeutics, Inc. and a Lead Plaintiff Deadline of January 9, 2017

PR Newswire December 16, 2016

SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of ProNAi Therapeutics Inc and Encourages Investors with Losses to Contact the Firm

Business Wire December 15, 2016

Opinion & Analysis (NDAQ:DNAI)

No current opinion is available.

Bullboard Posts (NDAQ:DNAI)